Juan Jiménez Cauhé

Dr. Juan Jiménez Cauhé

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in Clinical and Experimental Dermatology
Verified
Journal Article
Open access
PDF file
JCJuan Jiménez Cauhé
Juan Jiménez Cauhé
DOD. Ortega‐Quijano
D. Ortega‐Quijano
ICIrene Carretero-Barrio
Irene Carretero-Barrio
ASA. Suarez‐Valle
A. Suarez‐Valle
David Saceda CorraloDavid Saceda Corralo
David Saceda Corralo
DFD. Fernandez‐Nieto
D. Fernandez‐Nieto
Conflict of interest: the authors declare that they have no conflicts of interest.

22 June 2020 in Clinical and Experimental Dermatology
Verified
Journal Article
Open access
PDF file
DFD. Fernandez‐Nieto
D. Fernandez‐Nieto
DOD. Ortega‐Quijano
D. Ortega‐Quijano
JCJuan Jiménez Cauhé
Juan Jiménez Cauhé
PBP. Burgos‐Blasco
P. Burgos‐Blasco
DPD. Perosanz‐Lobo
D. Perosanz‐Lobo
MFM. Fernandez‐Guarino
M. Fernandez‐Guarino
Summary. COVID‐19 is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS‐CoV‐2). Vesicular skin rashes have been reported as associated

1 August 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JCJuan Jiménez Cauhé
Juan Jiménez Cauhé
DODaniel Ortega-Quijano
Daniel Ortega-Quijano
MPMarta Prieto-Barrios
Marta Prieto-Barrios
OMOscar M. Moreno-Arrones
Oscar M. Moreno-Arrones
DFDiego Fernandez-Nieto
Diego Fernandez-Nieto

1 August 2019 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
JCJuan Jiménez Cauhé
Juan Jiménez Cauhé
DSDavid Saceda-Corralo
David Saceda-Corralo
RRRita Rodrigues-Barata
Rita Rodrigues-Barata
AHAngela Hermosa-Gelbard
Angela Hermosa-Gelbard
OMOscar M. Moreno-Arrones
Oscar M. Moreno-Arrones
SVSergio Vaño-Galvan
Sergio Vaño-Galvan

4 June 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
DFD. Fernandez‐Nieto
D. Fernandez‐Nieto
DOD. Ortega‐Quijano
D. Ortega‐Quijano
GSG. Segurado‐Miravalles
G. Segurado‐Miravalles
CPCristina Pindado-Ortega
Cristina Pindado-Ortega
MPM. Prieto‐Barrios
M. Prieto‐Barrios
JCJuan Jiménez Cauhé
Juan Jiménez Cauhé
We have read with great interest the article: Cutaneous manifestations in COVID‐19: a first perspective by Recalcati S.1 This article is the first report of the cutaneous manifestations in Coronavirus Disease 2019 (COVID‐19) patients during the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic in Lombardy, Italy.

30 March 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
PDF file
DFD. Fernandez‐Nieto
D. Fernandez‐Nieto
JHJ. Hammerle
J. Hammerle
MFM. Fernandez‐Escribano
M. Fernandez‐Escribano
CRC.M. Moreno‐Del Real
C.M. Moreno‐Del Real
PGP. Garcia‐Abellas
P. Garcia‐Abellas
MFM. Fernandez‐Guarino
M. Fernandez‐Guarino
The coronavirus disease 2019 (COVID‐19) has been associated to a wide clinical spectrum of skin manifestations, including chilblain‐like, urticarial, vesicular, maculopapular, livedoid and vasculitic lesions, among others1,2. However, the exact pathophysiology for the appearance of skin lesions is still unknown. Several hypotheses have been suggested, including viral hypersensitivity reactions, overexpression of type I interferons, COVID‐19 induced coagulopathy, thrombotic microangiopathy and direct viral damage3–6.